Creative Marketing
    Legal specialists

    Marketing Agency for Personal Injury Solicitors

    Signed cases acquired directly, instead of buying the same recycled claims leads as everyone else.

    What does a marketing agency for personal injury solicitors actually do?

    A personal injury marketing agency builds direct case acquisition for claimant firms. The work is search visibility on injury and negligence terms, campaigns tuned to case value rather than volume, credibility content that survives an anxious client's scrutiny, and intake that signs a case before a competitor calls back.

    Get My Personal Injury Marketing Audit →

    Reviewed by Kasim Javed · Last reviewed 17 August 2026

    Case value
    The only sensible measure

    One serious injury case outweighs hundreds of low-value claims.

    Recycled
    The problem with bought leads

    The same claimant is sold to several firms at once.

    Minutes
    Speed to contact after enquiry

    Claimants sign with whoever reaches them first.

    Why this sector is different

    What makes marketing a personal injury firm different

    Personal injury has been reshaped by reform. Low-value road traffic work has been squeezed to the point where volume acquisition rarely pays, while clinical negligence and serious injury cases carry values that justify serious marketing investment.

    Most firms buy leads from brokers. Those leads are frequently sold to several firms simultaneously, so conversion is poor and the client's first experience is being called by four solicitors in an afternoon.

    Claimants are anxious and unfamiliar with the process. They are not comparing legal skill, they are looking for evidence that this firm will handle it properly and that it will not cost them anything they cannot afford.

    SRA rules on claims-related advertisingConditional fee agreements and no win no feeClinical negligence and serious injury claimsWhiplash reform and the OIC portalAPIL and AvMA membershipClaims management companies and lead brokersMedCo medical reportingProclaim and Clio case management
    The real problems

    What actually holds personal injury solicitors back

    Dependence on bought leads

    Broker leads are expensive, shared and declining in quality, and they build no asset the firm owns.

    Chasing volume in a reformed market

    Low-value RTA work no longer supports the acquisition costs many firms are still paying for it.

    Slow intake on high-value cases

    Clinical negligence enquiries need a fast, expert triage. A delayed callback loses cases worth six figures.

    Trust deficit

    The sector's advertising history makes claimants sceptical. Firms that look like a claims company get treated like one.

    No case-level attribution

    Without tracking source through to signed and settled cases, firms optimise for enquiries that never convert.

    How customers find you

    How people actually choose a personal injury firm

    Injury and negligence search

    'can I claim for a misdiagnosis', 'accident at work claim', 'surgical negligence solicitor' — specific, urgent and directly instructable.

    Process and cost questions

    'is no win no fee really free', 'how long does a claim take' — the reassurance phase where trust is earned.

    Reviews and outcomes

    Claimants read reviews for evidence of communication and settled outcomes, not legal argument.

    Referral from support organisations

    Charities, unions and support groups drive a large share of serious injury instructions.

    Free Personal Injury Marketing Audit

    Own your case flow instead of renting it

    We review your case mix, cost per signed case, intake speed and reliance on bought leads, then show you what a direct acquisition pipeline would be worth.

    No spam. Unsubscribe any time.

    What we do

    How we grow personal injury solicitors

    1

    Build direct acquisition to replace bought leads

    Owned search visibility and campaigns on injury-type terms, so the firm speaks to a claimant nobody else has been sold.

    2

    Concentrate on high-value case types

    Clinical negligence, serious injury, industrial disease and complex liability work, where marketing economics still function.

    3

    Explain funding without jargon

    Clear, compliant explanations of conditional fee agreements and what a claimant would ever have to pay. This is the single biggest conversion barrier.

    4

    Triage fast and expertly

    Immediate response with a qualified triage that assesses limitation, liability and prospects before a competitor makes contact.

    5

    Publish anonymised outcomes

    Case examples with consent, showing process and result, build the credibility broker-fed competitors cannot.

    6

    Attribute to signed and settled

    Track source through case management to signed cases and settlements so budget follows genuine value.

    Personal injury marketing scorecard

    MetricWhat good looks likeWhy it matters
    Cost per signed caseTracked by case typeCost per lead is meaningless here.
    Speed to first contactMinutesClaimants sign with the first firm that calls.
    Direct versus bought mixRising direct shareOwned demand converts far better.
    Case type mixWeighted to high valueReform removed the volume economics.
    Enquiry to signed rateMeasured per sourceReveals which channels actually work.

    Targets are set against your case values, funding model and appetite for risk.

    How we work with personal injury solicitors

    1

    Model case economics

    We establish what a signed case is worth by type so acquisition budgets are grounded in reality.

    2

    Audit intake and triage

    We test response speed and qualification, which usually explains more lost cases than traffic does.

    3

    Build owned demand

    Injury-type content and campaigns that reach claimants before a broker does.

    4

    Make funding understandable

    Compliant, plain-English explanations of costs and risk that remove hesitation.

    5

    Attribute end to end

    Source tracking through to signed and settled cases.

    Marketing inside SRA claims advertising expectations

    • No guarantees of success, compensation amounts or settlement timescales.
    • Funding arrangements described accurately, including any circumstances in which a client could be liable for costs.
    • No unsolicited approaches to potential claimants, and no cold calling.
    • Case examples published only with consent and with identifying detail removed.
    • Claimant data captured through forms and chat handled under UK GDPR with strict retention.
    FAQ

    Personal Injury Solicitors marketing: your questions answered

    By owning the search demand for specific injury and negligence types, responding within minutes, and publishing credibility content and anonymised outcomes. Direct enquiries convert far better than shared broker leads.

    Rarely as a primary strategy. They are typically sold to several firms, convert poorly and build no asset. They can supplement a direct pipeline but should be measured on cost per signed case.

    Clinical negligence, serious injury, industrial disease and complex liability work. Reform has largely removed the economics from low-value road traffic claims.

    It works where case values support high click costs, particularly clinical negligence and serious injury. It requires attribution to signed cases, not enquiries, or spend escalates fast.

    Yes, provided the explanation is accurate and includes any circumstances where a client could face costs. Misleading 'completely free' claims create both regulatory and reputational risk.

    Minutes. Claimants frequently contact several firms, and the firm that speaks to them first signs a disproportionate share of cases.

    Anonymised case outcomes can be published with client consent, presented as examples rather than as an expectation of what any new client would receive.

    Own your case flow instead of renting it

    We review your case mix, cost per signed case, intake speed and reliance on bought leads, then show you what a direct acquisition pipeline would be worth.